July 23, 2014 -- A new study by the US Centers for Disease Control and Prevention (Emerging Infectious Diseases, May 2014, Vol. 20:5, pp. 822-828) says vaccines that are currently available for the human papillomavirus (HPV) could prevent most oropharyngeal (OP) cancers in the U.S., according to DrBicuspid.com. The retrospective study of patients with oropharyngeal squamous cell carcinoma (OPSCC) found that most were HPV-positive, especially for HPV types 16 and 18, and the majority of patients were white men.
To read the full article at DrBicuspid.com, click here.